Danaher beat Q2 estimates and raised its 2025 earnings guidance as bioprocessing strength and cost control boosted profit margins and revenue.
Latest Ratings for DHR
DateFirmActionFromTo Jan 2022Wells FargoMaintainsOverweight Jan 2022BarclaysMaintainsOverweight Jan 2022BernsteinInitiates Coverage OnOutperform